Free Trial

SQZ Biotechnologies (SQZ) Competitors

SQZ Biotechnologies logo
$0.02
0.00 (0.00%)
(As of 11/1/2024 ET)

SQZ vs. USDP, CISS, AIRTP, BLDEW, RA, CMBT, FLNG, IMPPP, PXSAW, and PXSAP

Should you be buying SQZ Biotechnologies stock or one of its competitors? The main competitors of SQZ Biotechnologies include USD Partners (USDP), C3is (CISS), Air T (AIRTP), Blade Air Mobility (BLDEW), Brookfield Real Assets Income Fund (RA), Euronav (CMBT), FLEX LNG (FLNG), Imperial Petroleum (IMPPP), Pyxis Tankers (PXSAW), and Pyxis Tankers (PXSAP). These companies are all part of the "transportation" industry.

SQZ Biotechnologies vs.

USD Partners (NYSE:USDP) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap transportation companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, community ranking, analyst recommendations, institutional ownership, media sentiment and dividends.

In the previous week, USD Partners had 2 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 2 mentions for USD Partners and 0 mentions for SQZ Biotechnologies. USD Partners' average media sentiment score of 0.00 equaled SQZ Biotechnologies'average media sentiment score.

Company Overall Sentiment
USD Partners Neutral
SQZ Biotechnologies Neutral

USD Partners received 337 more outperform votes than SQZ Biotechnologies when rated by MarketBeat users. Likewise, 66.73% of users gave USD Partners an outperform vote while only 66.67% of users gave SQZ Biotechnologies an outperform vote.

CompanyUnderperformOutperform
USD PartnersOutperform Votes
347
66.73%
Underperform Votes
173
33.27%
SQZ BiotechnologiesOutperform Votes
10
66.67%
Underperform Votes
5
33.33%

USD Partners has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, SQZ Biotechnologies has a beta of 2.34, meaning that its share price is 134% more volatile than the S&P 500.

USD Partners has a net margin of -64.50% compared to SQZ Biotechnologies' net margin of -369.96%. USD Partners' return on equity of 0.00% beat SQZ Biotechnologies' return on equity.

Company Net Margins Return on Equity Return on Assets
USD Partners-64.50% N/A -28.33%
SQZ Biotechnologies -369.96%-119.83%-59.90%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USD Partners
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
SQZ Biotechnologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

USD Partners has higher revenue and earnings than SQZ Biotechnologies. USD Partners is trading at a lower price-to-earnings ratio than SQZ Biotechnologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
USD Partners$72.32M0.01$17.77M-$0.77-0.03
SQZ Biotechnologies$18.16M0.04-$79.46M-$2.61-0.01

0.1% of USD Partners shares are owned by institutional investors. Comparatively, 38.5% of SQZ Biotechnologies shares are owned by institutional investors. 2.6% of USD Partners shares are owned by company insiders. Comparatively, 16.0% of SQZ Biotechnologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

USD Partners beats SQZ Biotechnologies on 9 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SQZ vs. The Competition

MetricSQZ BiotechnologiesBiological Products IndustryMedical SectorNYSE Exchange
Market Cap$678,000.00$3.14B$5.50B$19.26B
Dividend YieldN/A1.77%5.11%3.53%
P/E Ratio-0.0116.11124.2742.61
Price / Sales0.04397.961,494.7514.52
Price / CashN/A149.0539.7820.88
Price / Book0.014.024.775.40
Net Income-$79.46M-$42.25M$119.06M$985.39M
7 Day PerformanceN/A8.04%0.80%-0.71%
1 Month PerformanceN/A8.69%5.65%-0.97%
1 Year PerformanceN/A32.09%36.75%25.05%

SQZ Biotechnologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SQZ
SQZ Biotechnologies
N/A$0.02
flat
N/AN/A$678,000.00$18.16M-0.011,620
USDP
USD Partners
N/A$0.02
flat
N/A-93.4%$829,000.00$72.32M-0.0390Analyst Forecast
News Coverage
Gap Up
CISS
C3is
0.4447 of 5 stars
$1.19
+0.8%
N/A-96.9%$440,000.00$28.74M0.03N/AShort Interest ↑
Negative News
AIRTP
Air T
N/A$17.46
+0.1%
N/A-10.2%$0.00$281.81M0.00500Positive News
BLDEW
Blade Air Mobility
N/A$0.28
+12.0%
N/A+64.7%$0.00$238.38M0.00130Positive News
Gap Up
RA
Brookfield Real Assets Income Fund
0.1256 of 5 stars
$13.45
+1.1%
N/A+10.1%$0.00$80.43M-122.27N/ANegative News
CMBT
Euronav
N/A$13.78
-0.9%
N/AN/A$0.00$1.24B2.293,216Upcoming Earnings
Short Interest ↑
News Coverage
FLNG
FLEX LNG
0.5101 of 5 stars
$24.25
-1.0%
$24.00
-1.0%
-21.2%$0.00$371.02M10.928
IMPPP
Imperial Petroleum
N/A$25.25
+1.4%
N/A+29.3%$0.00$147.51M0.00N/ANegative News
PXSAW
Pyxis Tankers
N/A$0.58
+1.8%
N/A-30.2%$0.00$50.06M0.004Gap Up
PXSAP
Pyxis Tankers
N/A$24.97
0.0%
N/A+7.2%$0.00$50.06M0.004Positive News

Related Companies and Tools


This page (NYSE:SQZ) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners